Atika Capital Management LLC Dice Therapeutics, Inc. Transaction History

Atika Capital Management LLC

  • $874 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$22.41 - $37.54 $636,197 - $1.07 Million
-28,389 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$31.92 - $37.0 $906,176 - $1.05 Million
28,389 New
28,389 $930,000

Others Institutions Holding DICE

# of Institutions
3
Shares Held
17.7K
Call Options Held
13K
Put Options Held
0
View Full List

About DICE Therapeutics, Inc.

DICE Quotes by TradingView
  • Ticker DICE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,430,000
  • Description
  • DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...
More about DICE
Track This Portfolio

Track Atika Capital Management LLC Portfolio

Follow Atika Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atika Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email